Drug confirmed effective on coronavirus being produced in Guangzhou
2020-02-19 22:49:24 GPHL GPHL
A total of half a million units of Chloroquine Phosphate, a drug effective for symptom management of COVID-19, have rolled off the production line in Guangzhou. Another 500,000 tablets are now being produced.
Guanghua’s Approval is only valid during the epidemic. This drug produced according to this regulation will not come onto the market until this first batch passes Guangdong Institute for Drug Control’s tests.
In addition, GPHL will make full use of its international resources. More than 200,000 Chloroquine Phosphate tablets the group has purchased from Pakistan will be reserved for the province and Guangzhou, and used in local clinical trials.
Chloroquine Phosphate is an anti-malarial that has been in use for over 70 years. Previous clinical research clearly indicate that it not only prevents and treats malaria, but also shows antiviral properties against a large spectrum of viruses. The drug also has known immune system regulating properties.
Authors: Michelle Wang, Monica Liu
Editor: Simon Haywood